Camden and Islington NHS Foundation Trust provides mental health, substance misuse services and care for people with learning disabilities in part of London, England. It operates on over twenty sites in Camden and Islington, but by far the largest site, and the location of its administrative headquarters, is the St Pancras site. The Trust owns the site which has some other health providers as tenants occupying a small part of it.It runs St Pancras Hospital which, as the name suggests is the main occupant of the St Pancras site.It was the first Care Trust to be awarded NHS Foundation Trust status, in 2008. The first Chair of the Trust to be appointed after it became a Foundation Trust was Richard Arthur. In the event it was his last public appointment (previous appointments had included Leader of Camden Council) as he chose to retire in September 2013, after four and a half years in post. He was succeeded as Chair of the Trust by former chief executive of Islington Council Leisha Fullick. The appointment was made, after public advertisement and interview, on the proposal of the Nominations Committee of the Trust, and ratified by a vote, after discussion, of the Council of Governors. The Remuneration and Nominations committee, to give it its full title, also oversees the appointment process for the Non Executive Directors of the Trustand also makes recommendations regarding pay and conditions. It consists of the Chair of the Trust, the Senior Independent Director of the Trust, and a majority of Governors elected by the Council of Governors. The chair of the committee is chosen by the committee, and the current (2015) chair is Wendy Savage.It was named by the Health Service Journal as one of the top hundred NHS trusts to work for in 2015. At that time it had 1774 full time equivalent staff and a sickness absence rate of 2.54%. 55% of staff recommend it as a place for treatment and 56% recommended it as a place to work.The trust started using the Carenotes electronic patient record system which can be accessed from mobile devices in September 2015..
Summary Antipsychotic non-adherence, driven partly by stigma, worsens outcomes in severe mental illness. Beyond ameliorating psychosis, evidence shows sustained antipsychotic treatment reduces mortality, cardiovascular risk, suicide, inflammation and cognitive decline, while improving quality of life. Reframing antipsychotics as essential medical care may reduce stigma and improve engagement with patients and clinicians.
Adult community intellectual disability services in the United Kingdom (UK) are required to deliver specialist, evidence-based care for a variety of conditions while minimising restrictive practices and reliance on inpatient provision. Care pathway models have emerged as a potential mechanism to reconcile these aims yet remain under-used in care philosophies in intellectual disabilities. We propose a generalisable pathways model for community intellectual disability services and examine its implications for policy, clinical practice, and research. The model integrates care navigation, proportionate specialist input, and defined clinical condition care including behaviours that challenge, mental and physical health, forensics, neurodevelopmental conditions, epilepsy, and dementia within a community-based service architecture. It considers recent focus on digitalsation, prevention, workforce and practice innovation. The model aligns with contemporary policy priorities. We argue that pathway-based care delivery provides a pragmatic and ethically grounded framework for organising services. It supports consistency, integration, and preventative care while reducing reliance on reactive risk-based responses. By synthesising service design principles, core pathway functions, and system interfaces, this paper offers a coherent model for contemporary community intellectual disability services. Further empirical evaluation is required to assess the impact of care pathways on outcomes, patient experience, and cost-effectiveness.
In its 2025 medical training review, National Health Service (NHS) England highlighted the urgent need to modernise postgraduate medical education in England to meet NHS population needs while supporting doctors’ professional aspirations. The psychiatry of intellectual disability, a subspecialty marked by declining recruitment, uneven service provision and limited research capacity, provides a critical test case for these reforms. This article applies the 11 recommendations from the review to doctors training in this subspecialty. Drawing on recent evidence, it advocates for equitable, flexible and academically grounded reforms that embed psychiatry of intellectual disability within mainstream medical education, workforce planning and national health policy transformation.
This overview study investigates integrating advanced manufacturing technologies, specifically metal additive manufacturing (AM) and laser powder bed fusion (LPBF) processes, within Industry 4.0 and Industry 5.0 frameworks, to enhance sustainability and efficiency in industrial production and prototyping. The manufacturing sector, a significant contributor to global greenhouse gas emissions and resource consumption, is increasingly adopting technologies that reduce environmental impact while maintaining economic growth. Selective laser melting (SLM), as the subsection LPBF technologies, is highlighted for its capability to produce high-performance, lightweight, and complex components with minimal material waste, thus aligning with circular economy goals for metal alloys. Life cycle assessment (LCA) and life cycle costing (LCC) analyses are essential methods for evaluating the sustainability of any new technology. Sustainable technologies could support the concepts of the factory of the future (FoF), fulfilling the requirements of digital transformation and digital twins. This overview study reveals that implementing AM—specifically SLM—has the potential to reduce the environmental impact of manufacturing. It underscores the ability of these technologies to promote sustainable and efficient manufacturing practices, thereby accelerating the shift from Industry 4.0 to Industry 5.0.
